Mesenchymal stem cells (MSCs) are considered to be an effective tool for treating chronic diseases due to their multi-lineage differentiation potential, immune regulatory capabilities, and ability to secrete anti-inflammatory factors. Increasingly, scientists are applying MSCs in clinical research for the treatment of chronic diseases such as neurodegenerative diseases, autoimmune diseases, and cardiovascular diseases and have achieved positive clinical outcomes.